Mithra Pharmaceuticals (Belgium) Today
| MITRA Stock | EUR 0.22 0.01 4.35% |
Performance0 of 100
| Odds Of DistressLess than 43
|
Mithra Pharmaceuticals is trading at 0.22 as of the 23rd of April 2024, a -4.35 percent down since the beginning of the trading day. The stock's open price was 0.23. Mithra Pharmaceuticals has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Mithra Pharmaceuticals SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Mithra Pharmaceuticals S.A. develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Mithra Pharmaceuticals S.A. was founded in 1999 and is headquartered in Lige, Belgium. The company has 56.31 M outstanding shares. More on Mithra Pharmaceuticals SA
Moving together with Mithra Stock
| 0.88 | ELI | Elia Group SANV | PairCorr |
Moving against Mithra Stock
| 0.9 | UCB | UCB SA Earnings Call Tomorrow | PairCorr |
| 0.63 | DIE | DIeteren Group SA | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Mithra Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mithra Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mithra Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Francois Fornieri |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Mithra Pharmaceuticals SA (MITRA) is traded on Euronext Brussels in Belgium and employs 300 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 157.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mithra Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Mithra Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mithra Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 56.31 M outstanding shares.
Mithra Pharmaceuticals SA has accumulated about 118.95 M in cash with (74.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Mithra Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationMithra Pharmaceuticals SA holds a total of 56.31 Million outstanding shares. Mithra Pharmaceuticals SA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Mithra Ownership Details
Mithra Stock Price Odds Analysis
What are Mithra Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Mithra Pharmaceuticals jumping above the current price in 90 days from now is about 81.12%. The Mithra Pharmaceuticals SA probability density function shows the probability of Mithra Pharmaceuticals stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Mithra Pharmaceuticals SA has a beta of -1.2541. This indicates as returns on its benchmark rise, returns on holding Mithra Pharmaceuticals SA are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Mithra Pharmaceuticals is expected to outperform its benchmark. Additionally, mithra Pharmaceuticals SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Mithra Pharmaceuticals to move above the current price in 90 days from now is about 81.12 (This Mithra Pharmaceuticals SA probability density function shows the probability of Mithra Stock to fall within a particular range of prices over 90 days) .
Mithra Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Mithra Pharmaceuticals market risk premium is the additional return an investor will receive from holding Mithra Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mithra Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Mithra Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Mithra Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.15 | |||
| Standard Deviation | 8.02 | |||
| Variance | 64.25 | |||
| Risk Adjusted Performance | (0.15) |
Mithra Stock Against Markets
Picking the right benchmark for Mithra Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mithra Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mithra Pharmaceuticals is critical whether you are bullish or bearish towards Mithra Pharmaceuticals SA at a given time. Please also check how Mithra Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mithra Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Mithra Pharmaceuticals Corporate Directors
Mithra Pharmaceuticals corporate directors refer to members of a Mithra Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Mithra Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Mithra Pharmaceuticals' board members must vote for the resolution. The Mithra Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jean Sequaris | Independent Director | Profile | |
| Guy Debruyne | Non-Executive Director - Representing CG Cube SA | Profile | |
| Freddy Meurs | Non-Executive Director - Representing CEFMA Consult SPRL | Profile | |
| Koen Hoffman | Independent Director - Representing Ahok BVBA | Profile |
How to buy Mithra Stock?
Before investing in Mithra Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Mithra Pharmaceuticals. To buy Mithra Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Mithra Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Mithra Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Mithra Pharmaceuticals SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Mithra Pharmaceuticals SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Mithra Pharmaceuticals SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Mithra Pharmaceuticals SA?
The danger of trading Mithra Pharmaceuticals SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mithra Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mithra Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mithra Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mithra Pharmaceuticals SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Mithra Pharmaceuticals information on this page should be used as a complementary analysis to other Mithra Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Mithra Stock analysis
When running Mithra Pharmaceuticals' price analysis, check to measure Mithra Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mithra Pharmaceuticals is operating at the current time. Most of Mithra Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Mithra Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mithra Pharmaceuticals' price. Additionally, you may evaluate how the addition of Mithra Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |